Tizona Therapeutics
PrivateLast Round
Corporate Funding
Jul 21, 2020
Est. Valuation
$601.2M
Total Funding Raised
$475M
Company Overview
Tizona Therapeutics is a biotechnology company that develops first-in-class immunotherapies to treat cancer and autoimmune diseases by modulating immunosuppressive cell activity in the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tizona Therapeutics Comparables
Compare Tizona Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trishula Therapeutics | 92% | |
| Immune-Onc Therapeutics | 84% | |
| OncoResponse | 81% | |
Tizona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 21, 2020 | ||||
| Strategic | Jan 3, 2019 | ||||
| Series B | Mar 8, 2016 | ||||
| Series A | Jan 1, 2016 |
Key People
Founding team and executive leadership
Tizona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Series B |
| InterWest Partners | Series B, Series A |
| Lightstone Ventures | Series B |
| MPM BioImpact | Series B, Series A |
| Amgen Ventures | Series B, Series A |
| Abingworth | Series B |
| Canaan Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 3, 2019
$105M round led by AbbVie and Astellas Venture Management.
- Mar 8, 2016
$43M round led by Canaan Partners and Abingworth.
Tizona Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tizona Therapeutics's valuation, stock price, and market status.